COMPOSITION:
Contains per ml:
Buparvaquone 50 mg.
Solvents ad 1 ml
DESCRIPTION:
Buparvaquone is a second-generation hydroxynaphtaquinone with novel features that make it an effective compound for the therapy and prophylaxis of all forms of theileriosis.
INDICATIONS
For treatment of tick-transmitted theileriosis caused by the intracellular protozoan parasites Theileria parva (East Coast fever, Corridor disease, Zimbabwean theileriosis) and T. annulata (tropical theileriosis) in cattle. It is active against both the schizont and piroplasm stages of Theileria spp., and may be used during the incubation period of the disease, or when clinical signs are apparent.
CONTRAINDICATIONS:
Due to the inhibiting effects of theileriosis on the immune system, vaccination should be delayed until the animal has recovered from theileriosis.
SIDE EFFECT:
Localised, painless, oedematous swelling may occasionally be seen at the injection site.
DOSAGE AND ADMINISTRATION:
For intramuscular injection.
The general dosage is 1 ml per 20 kg body weight.
In severe cases the treatment may be repeated within 48-72 hours.
Do not administer more than 10 ml per injection site.
Successive injections should be administered at different sites.
WITHDRAWAL TIMES
- For meat: 42 days.
- For milk: 2 days.
WARNING:
Keep out of reach of children.